Berry, James et al "A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067)." Neurology 84.14 Supplement (2015): P7.067. Web. 27 May. 2022.